Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -38.51%-36.53K | -767.28%-310.89K | -536.91%-88.45K | -177.17K | -97.21%-18.91K | -113.12%-26.37K | 94.99%-35.85K | 90.53%-13.89K | 0 | 94.93%-9.59K |
| Net income from continuing operations | 10,517.39%1.41M | -408.19%-676.08K | 271.64%81.05K | ---685.32K | -103.76%-58.29K | 76.35%-13.53K | 81.79%-133.04K | 57.67%-47.22K | --0 | 82.57%-28.61K |
| Operating gains losses | ---42.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 0.00%5K | -23.00%20K | -50.00%5K | --5K | 0.00%5K | -54.44%5K | -42.73%25.97K | -11.67%10K | --0 | -55.54%5K |
| Remuneration paid in stock | ---- | --61.32K | ---10.88K | --37.31K | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non cashItems | ---1.43M | --252.94K | ---114.75K | --366.96K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 217.99%21.05K | -56.57%30.93K | -309.25%-48.83K | --98.83K | -108.85%-1.24K | -152.68%-17.84K | 154.65%71.22K | 150.20%23.33K | --0 | 138.92%14.02K |
| -Change in receivables | -525.22%-4.19K | -29.42%-4.85K | 56.90%-774 | ---2.63K | 49.77%-777 | -65.02%-670 | 74.10%-3.75K | -35.55%-1.8K | --0 | 63.90%-1.55K |
| -Change in prepaid assets | 175.86%3.79K | -176.82%-20.01K | ---20.01K | --5K | --0 | -129.43%-5K | 200.00%26.05K | --0 | --0 | 115.10%9.06K |
| -Change in payables and accrued expense | 276.22%21.45K | 14.07%55.79K | -211.57%-28.04K | --96.46K | -107.13%-464 | -170.44%-12.17K | 154.48%48.91K | 140.44%25.13K | --0 | -77.02%6.5K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -38.51%-36.53K | -767.28%-310.89K | -536.62%-88.41K | ---177.21K | -97.21%-18.91K | -113.12%-26.37K | 94.99%-35.85K | 90.53%-13.89K | --0 | 94.93%-9.59K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -116.67%-5K | 1,079.17%353.75K | 100K | 218.75K | -83.33%5K | 30K | -33.33%30K | 0 | 0 | 30K |
| Net issuance payments of debt | -116.67%-5K | --3.75K | --0 | ---31.25K | --5K | --30K | --0 | --0 | --0 | --0 |
| Net common stock issuance | ---- | --350K | --100K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | ---- | ---- | -33.33%30K | --0 | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -116.67%-5K | 1,079.17%353.75K | --100K | --218.75K | -83.33%5K | --30K | -33.33%30K | --0 | --0 | --30K |
| Net cash flow | ||||||||||
| Beginning cash position | 365.07%54.6K | -33.25%11.74K | 87.19%43.01K | -94.29%1.46K | 194.82%15.37K | -33.25%11.74K | -97.44%17.59K | -86.02%22.98K | -93.05%25.63K | -99.07%5.21K |
| Current changes in cash | -1,244.28%-41.53K | 833.01%42.86K | 203.18%11.59K | 1,666.48%41.54K | -168.12%-13.91K | 129.33%3.63K | 99.13%-5.85K | 92.34%-11.24K | 98.70%-2.65K | 110.80%20.41K |
| End cash Position | -14.94%13.07K | 365.07%54.6K | 365.07%54.6K | 87.19%43.01K | -94.29%1.46K | 194.82%15.37K | -33.25%11.74K | -33.25%11.74K | -86.02%22.98K | -93.05%25.63K |
| Free cash from | -38.51%-36.53K | -767.28%-310.89K | -536.62%-88.41K | ---177.21K | -97.21%-18.91K | -113.12%-26.37K | 94.99%-35.85K | 90.53%-13.89K | --0 | 94.93%-9.59K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.